Etienne Drouet has been appointed executive director of Oncology Europe at Premier Research Group. Mr. Drouet will play a leading role in the operations, strategic planning and corporate development of the company’s portfolio of oncology business.
 
“Etienne brings a tremendous amount of operational knowledge and oncology acumen serving the needs of our customers,” said Dr. Sue Stansfield, executive vice president, Clinical Development.
 
Mr. Drouet has more than 19 years of experience in drug development, including 14 years in clinical research and five years as a research scientist for oncology clinical trials. Mr. Drouet has held positions of increasing responsibility at pharmaceutical, contract research, and investigational cooperative groups including Rhône Poulenc Rorer (Sanofi Aventis), ICON, and Breast Cancer International Research Group.